Featured
January 13, 2025
Ouro Medicines Raises $120M Series A
Ouro Medicines, a San Francisco, CA-based biotechnology company developing immune reset therapeutics for people living... Read more »
January 13, 2025
Saluda Medical Raises $100M Funding
Saluda Medical, a Minneapolis, MN-based commercial-stage medical device company, raised $100M in funding... Read more »
January 13, 2025
RAAPID Raises Series A Funding From M12
RAAPID, a Louisville, KY-based healthcare AI company, raised a Series A investment from M12. The amount of the deal... Read more »
March 15, 2021
Robbins LLP Announces that Vanda Pharmaceuticals Class Action Survives Motion to Dismiss
